Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-14-001672
Filing Date
2014-03-24
Accepted
2014-03-24 17:07:02
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs32014_actinium.htm S-3 604575
2 SALES AGREEMENT fs32014ex1ii_actinium.htm EX-1.2 296714
3 LEGAL OPINION fs32014ex5i_actinium.htm EX-5.1 26016
4 CONSENT fs32014ex23i_actinium.htm EX-23.1 3649
5 img1.jpg GRAPHIC 37712
6 img3.jpg GRAPHIC 5294
7 img9.gif GRAPHIC 4794
  Complete submission text file 0001213900-14-001672.txt   998182
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-194768 | Film No.: 14713776
SIC: 6770 Blank Checks